
1. Eur J Med Chem. 2017 Nov 10;140:274-292. doi: 10.1016/j.ejmech.2017.09.026. Epub 
2017 Sep 19.

Synthesis, biological evaluation and quantitative structure-active relationships 
of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with 
high antifungal potency and low cytotoxicity.

Carradori S(1), Bizzarri B(2), D'Ascenzio M(2), De Monte C(2), Grande R(3),
Rivanera D(4), Zicari A(5), Mari E(5), Sabatino M(6), Patsilinakos A(7), Ragno
R(7), Secci D(8).

Author information: 
(1)Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Via dei 
Vestini 31, 66100 Chieti, Italy. Electronic address: simone.carradori@unich.it.
(2)Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza University of Rome,
P.le A. Moro 5, 00185 Rome, Italy.
(3)Department of Pharmacy, "G. d'Annunzio" University of Chieti-Pescara, Via dei 
Vestini 31, 66100 Chieti, Italy; Center for Aging Science and Translational
Medicine (CeSI-MeT), Via dei Vestini 31, 66100 Chieti, Italy.
(4)Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza University of
Rome, P.le A. Moro 5, 00185 Rome, Italy.
(5)Dipartimento di Medicina Sperimentale, Sapienza University of Rome, P.le A.
Moro 5, 00185 Rome, Italy.
(6)Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza University of Rome,
P.le A. Moro 5, 00185 Rome, Italy; Rome Center for Molecular Design, Dipartimento
di Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro 5,
00185 Rome, Italy.
(7)Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza University of Rome,
P.le A. Moro 5, 00185 Rome, Italy; Rome Center for Molecular Design, Dipartimento
di Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro 5,
00185 Rome, Italy; Alchemical Dynamics s.r.l., 00125 Rome, Italy.
(8)Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza University of Rome,
P.le A. Moro 5, 00185 Rome, Italy. Electronic address: daniela.secci@uniroma1.it.

With reference to recent studies reporting on the various biological properties
of the thiazolidinone scaffold, we synthesized more than a hundred compounds
characterized by a 1,3-thiazolidin-4-one nucleus derivatised at the C2 with a
hydrazine bridge linked to (cyclo)aliphatic or hetero(aryl) moieties, and their
N-benzylated derivatives. These molecules were assayed as potential anti-Candida 
agents and they were shown to possess comparable, and in some cases higher
biological activity than well-established topical and systemic antimycotic drugs 
(i.e. clotrimazole, fluconazole, ketoconazole, miconazole, tioconazole,
amphotericin B). Compounds endowed with the lowest MICs underwent further testing
in order to assess their cytotoxic effect (CC50) on Hep2 cells, which
demonstrated their relative safety. Finally, QSAR and 3-D QSAR models were used
to predict putative chemical modifications of the 1,3-thiazolidin-4-one scaffold 
in order to design new and potential more active compounds against Candida spp.

Copyright © 2017 Elsevier Masson SAS. All rights reserved.

DOI: 10.1016/j.ejmech.2017.09.026 
PMID: 28963991  [Indexed for MEDLINE]

